Amyloid beta protein and tau in cerebrospinal fluid and plasma as biomarkers for dementia: a review of recent literature.
about
Prediction of protein binding regions in disordered proteinsA blood based 12-miRNA signature of Alzheimer disease patientsClassification of genes and putative biomarker identification using distribution metrics on expression profilesModeling screening, prevention, and delaying of Alzheimer's disease: an early-stage decision analytic model.Neuropsychological Testing and Machine Learning Distinguish Alzheimer's Disease from Other Causes for Cognitive Impairment.Barrier dysfunction or drainage reduction: differentiating causes of CSF protein increase.Proteomic analysis of Alzheimer's disease cerebrospinal fluid from neuropathologically diagnosed subjects.Quantitative proteomics and metabolomics analysis of normal human cerebrospinal fluid samplesCSF phospho-tau correlates with behavioural decline and brain insoluble phospho-tau levels in a rat model of tauopathy.Effect of stent-assisted angioplasty on cognitive status and serum levels of amyloid beta in patients with intracranial and/or extracranial artery stenosis.Coordinated increase of γ-secretase reaction products in the plasma of some female Japanese sporadic Alzheimer's disease patients: quantitative analysis of p3-Alcα with a new ELISA system.Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trialMeasurement of altered AβPP isoform expression in frontal cortex of patients with Alzheimer's disease by absolute quantification real-time PCRBiofunctionalized magnetic nanoparticles for specifically detecting biomarkers of Alzheimer's disease in vitro.GC/MS-based metabolomic analysis of cerebrospinal fluid (CSF) from glioma patients.Amyloid-β Peptides and Tau Protein as Biomarkers in Cerebrospinal and Interstitial Fluid Following Traumatic Brain Injury: A Review of Experimental and Clinical Studies.Schizophrenia genomics and proteomics: are we any closer to biomarker discovery?Tau oligomers in cerebrospinal fluid in Alzheimer's disease.Current application of neurochemical biomarkers in the prediction and differential diagnosis of Alzheimer's disease and other neurodegenerative dementias.Genome-wide identification of microRNA-related variants associated with risk of Alzheimer's disease.Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia.No Evidence to Suggest that the Use of Acetylcholinesterase Inhibitors Confounds the Results of Two Blood-Based Biomarker Studies in Alzheimer's Disease.Cerebrospinal fluid metabolomic profiles can discriminate patients with leptomeningeal carcinomatosis from patients at high risk for leptomeningeal metastasis.Role of EEG as biomarker in the early detection and classification of dementia.
P2860
Q21145360-AE57970F-C7E9-4DCA-9204-A320545E0B03Q27499741-0A619A77-7EF9-4EBE-9FA4-22B54D375B18Q33530123-846994F0-8BBF-4AE0-9EA1-7F3D2F432AFEQ33569145-6DF9DDCC-1FE0-412C-950C-8DBD5192573DQ33599831-F2C50706-435B-4D9A-AF51-2A59285C8E36Q33706403-E7F864BA-227F-4997-AEF3-74EA7AAC1F4FQ33706600-A46F612E-9D4D-4EED-97E9-F3E527317565Q34122220-265F04A4-B765-4B3D-BADD-357F2C2B2B79Q35114771-BDAC75F2-A240-481C-BBCF-9F6171B3FC78Q35142732-5C689D57-5571-446C-8EFE-ABEB45767AE3Q35639365-27172F8D-D816-418B-AFAC-2F75F16F2446Q35679839-24286C66-51DF-4653-B331-94565FB97D10Q35886927-B64A4DE7-0054-470F-885B-56DDCAEB241AQ36015518-C9DE7795-33BD-499B-A786-12CECE3E0A08Q36798779-609E93DA-29D8-4F6D-8968-F2C8D6FB40CCQ36955963-37B2E2B1-80E2-4120-A74F-1992582BECD2Q37064920-63F4F561-FE99-4F6D-983A-B04A2E18BFC6Q37733987-FAABDBC4-C28E-4230-B3FC-5ECE44813155Q38044199-A40A8814-6683-464E-99AE-12906CC43B29Q40689258-AB4891E6-8780-4042-B989-00082907FA53Q40777128-580D4576-7EB3-493D-BE8C-30385A3F7FEDQ46631793-D017B26E-2D6C-441E-9EB7-59E75749D483Q47574127-90A90B30-1BA2-4E5F-8B6B-EEDE9111C6D4Q53480784-1F21D49F-9693-4912-B4C1-CD551A5ED199
P2860
Amyloid beta protein and tau in cerebrospinal fluid and plasma as biomarkers for dementia: a review of recent literature.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Amyloid beta protein and tau i ...... a review of recent literature.
@en
Amyloid beta protein and tau i ...... a review of recent literature.
@nl
type
label
Amyloid beta protein and tau i ...... a review of recent literature.
@en
Amyloid beta protein and tau i ...... a review of recent literature.
@nl
prefLabel
Amyloid beta protein and tau i ...... a review of recent literature.
@en
Amyloid beta protein and tau i ...... a review of recent literature.
@nl
P2093
P921
P1476
Amyloid beta protein and tau i ...... a review of recent literature.
@en
P2093
Jos H Beijnen
Jos P C M van Campen
Linda R Tulner
Marcel M Verbeek
René W M M Jansen
Suzanne V Frankfort
P304
P356
10.2174/157488408784293723
P577
2008-05-01T00:00:00Z